⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28486930 | 1.00 | — | — | |
| SCHEMBL29707222 | 1.00 | — | — | |
| Fluoride SCHEMBL28990878 | 0.98 | GSR (0.52) | — | |
| SCHEMBL30565594 | 0.93 | GSR (0.64) | — | |
| SCHEMBL29595628 | 0.93 | GSR (0.64) | — | |
| SCHEMBL29803185 | 0.84 | — | — | |
| SCHEMBL16272838 | 0.84 | — | — | |
| SCHEMBL29581742 | 0.78 | — | — | |
| SCHEMBL57938 | 0.77 | — | — | |
| SCHEMBL57939 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117530943-A | Formulations for administration of efluromithine | 奥巴斯治疗股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-115698321-A | Methods for plasma free RNA analysis | 格里尔公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-114096240-A | Method for treating familial adenomatous polyposis | 癌症预防制药股份有限公司 | 2022-02-25 | — | — | CN | disclosed |
| CN-112955438-A | Protein tyrosine phosphatase inhibitors and methods of use thereof | 卡里科生命科学有限责任公司 | 2021-06-11 | — | — | CN | disclosed |
| CN-112812183-A | anti-IL-36R antibodies | 勃林格殷格翰国际有限公司 | 2021-05-18 | — | — | CN | disclosed |
| CN-112204009-A | Modulators of integrated stress pathways | 卡里科生命科学有限责任公司 | 2021-01-08 | — | — | CN | disclosed |
| CN-107007833-B | anti-IL-36R antibodies | 勃林格殷格翰国际有限公司 | 2020-12-11 | — | — | CN | disclosed |